HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fengfu Fu Selected Research

Biomarkers (Surrogate Marker)

1/2022An Activatable Hybrid Organic-Inorganic Nanocomposite as Early Evaluation System of Therapy Effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fengfu Fu Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Mouth Neoplasms (Oral Cancer)
10/2010

Drug/Important Bio-Agent (IBA)

1Caspase 3 (Caspase-3)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1deoxyinosineIBA
10/2010
1DNA (Deoxyribonucleic Acid)IBA
10/2010

Therapy/Procedure

2Therapeutics
01/2022 - 02/2021
1Radiotherapy
01/2022
1X-Ray Therapy
02/2021
1Photothermal Therapy
01/2020
1Immunotherapy
01/2020